跳至主要内容
临床试验/CTRI/2024/11/076519
CTRI/2024/11/076519尚未招募不适用

A Polysomnographic Investigation of Sleep Disturbance In Patients With Chronic Low Back Pain

Jamia Millia Islamia1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2024年11月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
32
试验地点
1
主要终点
Pain intensity

研究概览

简要总结

The patients will be recruited from the community and the Centre for Physiotherapy and Rehabilitation Sciences(CPRS) clinic, Jamia Millia Islamia on the basis of the inclusion and exclusion criteria. Patients would be required to sign the consent form explaining the rights as research subjects. All the identifying information on the consent form and the demographic data shall be confidential. The assessment of the patient will include demographic data, anthropometric characteristrics and screening for chronic low back pain, following which the patients will be assessed for objective sleep using Polysomnography device, pain using NPRS, quality of life using WHOQOL-BREFF, subjective sleep quality using St. Mary’s Hospital Sleep Questionnaire and functional disability by 10-item Oswestry Disability Index.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
Male

入选标准

  • Chronic Low back Pain more than twelve weeks and less than seven years NPRS score of 3-7 participant who are healthy and free from physical illness Willingness to participate in the present study Working knowledge of the English language (to fill out the questionnaires and consent form).

排除标准

  • They will have a history of low back pain ≥ 7 years, leading to the development of coping with pain skills more than 50 years of age because of the decrease in slow wave sleep (SWS) that occurs in this age group Cognitive impairment that would limit their participation Participant who will be taking heavy caffeine (more than 350 mg/day), alcohol (more than 5 standard drinks per week), or other recreational drugs Participant who will be performing intense regular physical exercise Participant dealing with major life stress situations, such as examination preparation, job seeking, etc.
  • Participant already diagnosed with any sleep disorders Participant having any lifestyle disorders (hypertension, diabetes, hypothyroidism, etc) Subjects having chronic secondary musculoskeletal pain (pain due to inflammatory conditions, infections, auto-immune disease, nervous system disease, local structural musculoskeletal changes) Participant consuming any anti-inflammatory, antidepressant drugs such as benzodiazepine, B-blockers, or any other psychotic drugs that can affect pain, autonomic function, and sleep.
  • Psychological disorders, cognitive impairment for atleast six weeks Any associated cardiovascular disease (valvular heart disease, coronary artery disease, recent myocardial infarction, etc.).

结局指标

主要结局

Pain intensity

时间窗: On day 1

Functional disability

时间窗: On day 1

Objective sleep

时间窗: On day 1

次要结局

  • Subjective sleep quality(Quality of life)

研究者

申办方类型
Other [Central University ]
责任方
Principal Investigator
主要研究者

Dr Zubia Veqar

Centre For Physiotherapy and Rehabilitation Sciences, Jamia Millia Islamia

研究点 (1)

Loading locations...

相似试验

招募中
不适用
24-week, multicenter, randomized, double blinding, placebo-controlled human application trial for evaluating the efficacy and safety of GBE for age-related macular degeneration (AMD)Diseases of the eye and adnexa
KCT0009161The Catholic University of Korea, St. Vincent's Hospital100
进行中(未招募)
不适用
Estudio de 24 semanas, multicéntrico, doble ciego y con doble enmascaramiento, de búsqueda de dosis versus control activo para evaluar canakinumab (ACZ885) en la prevención de signos y síntomas de los episodios agudos en pacientes con gota crónica que inician tratamiento con allopurinol. - H2251
EUCTR2008-005876-28-ESovartis Farmacéutica S.A440
进行中(未招募)
不适用
A 24-weeks , national, multicenter, double blind controlled vs placebo trial to evaluate the efficacy of Neoral ciclosporine 5mg/kg/day , twice a week administered in reduction of the rate of relapse in pz with chronic plaque psoriasis on remission. PREWENT Study - PREWENT StudyChronic plaque psoriasis on remissionMedDRA version: 6.1Level: PTClassification code 10037153
EUCTR2006-000207-42-ITOVARTIS FARMA264
已完成
4 期
A Clinical Trial to compare the efficacy and safety of Fluticasone / Formoterol with Budesonide / Formoterol combination administered with an inhaler in subjects with moderate to severe asthma.
CTRI/2009/091/000258Cipla Ltd Bellasis Road Mumbai Central Mumbai Phone Fax236
已完成
3 期
A 24-week clinical study to check the efficacy and safety of QVM149 with a free triple combination of salmeterol/fluticasone plus tiotropium in patients with uncontrolled asthma.
CTRI/2018/08/015281ovartis Healthcare Private Limited71
An Investigation of Sleep Disturbance In Patients... | 临床试验